Prodigiosin Alleviates Pulmonary Fibrosis Through Inhibiting miRNA-410 and TGF-β1/ADAMTS-1 Signaling Pathway | Zendy

Hao Liu | Zendy; Yi He | Zendy; Zhaolei Jiang | Zendy; Saie Shen | Zendy; Mei Ju | Zendy; Min Tang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prodigiosin Alleviates Pulmonary Fibrosis Through Inhibiting miRNA-410 and TGF-β1/ADAMTS-1 Signaling Pathway

Author(s) -

Hao Liu,

Yi He,

Zhaolei Jiang,

Saie Shen,

Mei Ju,

Min Tang

Publication year - 2018

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000492989

Subject(s) - pulmonary fibrosis , hydroxyproline , bronchoalveolar lavage , prodigiosin , lung , fibrosis , pathology , fibroblast , medicine , viability assay , chemistry , cell , in vitro , biochemistry , escherichia coli , gene , serratia marcescens

Pulmonary fibrosis is a common outcome of various interstitial lung diseases. Prodigiosin (PG) is a series of red pigment with methoxypyrrole ring. This studyinvestigates therole of prodigiosin in pulmonary fibrosis and its underlying mechanisms.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research